Global Neuronavigation Systems Market Report and Forecast 2023-2031

Global Neuronavigation System Market Report and Forecast 2023-2031


Global Neuronavigation System Market Outlook


The global neuronavigation system market size is being driven by the rising prevalence of the condition across the globe. The market attained a value of 2.34 billion in 2022 and is likely to grow at a CAGR of 7.7% during the forecast period of 20323-2031 to attain a value of USD 4.58 billion by 2031.

Neuronavigation System Market: Introduction


Neuronavigation systems, also known as surgical navigation systems or intraoperative navigation systems, are advanced medical tools used in neurosurgery and other surgical procedures. They integrate imaging technology, such as magnetic resonance imaging (MRI) or computed tomography (CT), with real-time tracking and guidance systems to assist surgeons during delicate procedures involving the brain, spine, and other parts of the nervous system.

The primary goal of a neuronavigation system is to provide surgeons with accurate and precise information about the patient's anatomy and the surgical instruments' location in real-time. It allows surgeons to navigate through complex anatomical structures and perform minimally invasive or highly targeted procedures with improved accuracy and safety. Here are some common uses and benefits of neuronavigation systems:

Preoperative planning: Neuronavigation systems enable surgeons to study and analyze the patient's anatomy in detail before the actual surgery. By overlaying imaging data onto a 3D model of the patient's anatomy, surgeons can visualize the target area and plan the safest and most effective approach.
Surgical guidance: During surgery, neuronavigation systems provide real-time feedback and guidance to the surgeon. The system tracks the position of surgical instruments relative to the patient's anatomy and displays this information on a screen. This helps surgeons precisely navigate to the target area and avoid critical structures, reducing the risk of complications.
Tumour resection: Neuronavigation systems are commonly used in brain tumour surgeries. They help surgeons identify the tumour's location, define its boundaries, and navigate around critical structures to minimize damage to healthy tissue. The system can also update the surgical plan if unexpected shifts or deformations occur during the procedure.
Functional neurosurgery: In procedures like deep brain stimulation (DBS) or stereotactic radiosurgery, neuronavigation systems assist surgeons in accurately placing electrodes or radiation beams. This precision targeting helps optimize the therapeutic effect while minimizing side effects.
Spinal surgery: Neuronavigation systems are valuable in spinal procedures, such as spinal fusion or vertebral tumor resection. They aid in visualizing the spinal anatomy, confirming the correct level of intervention, and guiding the placement of screws or implants.
The benefits of neuronavigation systems include:

Enhanced surgical accuracy: Neuronavigation systems provide real-time feedback, allowing surgeons to navigate complex anatomical structures with greater precision and reduce the risk of errors.
Improved patient safety: By helping surgeons avoid critical structures, neuronavigation systems can minimize complications and reduce the risk of damage to healthy tissue, leading to better patient outcomes.
Minimally invasive approaches: Neuronavigation systems enable surgeons to perform minimally invasive procedures with more confidence, as they can precisely navigate to the target area while avoiding unnecessary tissue disruption.
Intraoperative adaptability: If there are unexpected changes in the patient's anatomy or the surgical plan, neuronavigation systems can quickly update the information and guide surgeons accordingly, enhancing surgical adaptability.
Overall, neuronavigation systems have revolutionized the field of neurosurgery by providing surgeons with advanced imaging, tracking, and guidance capabilities. These systems contribute to safer, more accurate, and efficient surgical interventions, ultimately benefiting patients undergoing neurosurgical procedures.

Neuronavigation System Market Segmentations


The market can be categorised into product, application, end user, and region.

Market Breakup by Product

Optical Systems
Electromagnetic Systems
Market Breakup by Application

Neurosurgery
ENT Surgery
Maxillofacial Surgery
Spinal Surgery
Others
Market Breakup by End User

Hospitals
Ambulatory Surgery Centres
Others
Neuronavigation System Market Breakup by Region

North America
United States of America
Canada
Europe
United Kingdom
Germany
France
Italy
Others
Asia Pacific
China
Japan
India
ASEAN
Australia
Others
Latin America
Brazil
Argentina
Mexico
Others
Middle East and Africa
Saudi Arabia
United Arab Emirates
Nigeria
South Africa
Others
Neuronavigation System Market Scenario

The global market for neuronavigation systems is experiencing considerable growth, driven primarily by the rising prevalence of various neurological disorders and the increasing demand for minimally invasive neurosurgical procedures. The market is witnessing a significant surge in demand due to conditions like Parkinson's disease, Alzheimer's disease, strokes, and brain tumours. The growing elderly population worldwide, which is more prone to these diseases, is further bolstering this demand.

Technological advancements play a pivotal role in shaping the neuronavigation system market. Cutting-edge innovations, such as the integration of artificial intelligence and machine learning, real-time imaging, and augmented reality, are revolutionizing the domain, leading to improved surgical outcomes and patient safety. These advancements not only provide high precision during surgeries but also reduce the operative time, thus driving their acceptance among neurosurgeons globally.

The competitive landscape of the neuronavigation system market is becoming increasingly dynamic, with several key players engaged in R&D activities to develop sophisticated systems. However, the high cost of these systems and the need for skilled professionals to operate them can act as significant barriers to market growth, particularly in developing and underdeveloped regions.

Regionally, North America holds a significant share of the neuronavigation system market, primarily due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of key market players. Europe follows closely, with a robust healthcare system and significant funding for research and development activities. The Asia Pacific region is anticipated to witness the fastest growth, attributed to the increasing healthcare spending, improving healthcare infrastructure, and growing awareness about advanced neurological treatment options.

In terms of product type, optical neuronavigation systems are leading the market due to their high accuracy and real-time feedback features. Electromagnetic neuronavigation systems are also gaining traction due to their ability to perform procedures without line-of-sight issues.

In conclusion, the neuronavigation system market is on a promising growth trajectory, with technological advancements, rising disease prevalence, and increasing acceptance of minimally invasive procedures acting as key driving factors. Nevertheless, challenges such as high costs and the requirement for skilled personnel pose substantial hurdles for market expansion, especially in resource-limited settings.

Key Players in the Global Neuronavigation System Market


The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the neuronavigation system market are as follows:

Stryker
BrainLAB AG
Brainbox Ltd.
Medtronic
7D Surgical System
B. Braun Melsungen AG
Siemens Healthineers
Zimmer Biomet Holding Inc.
Brainlab AG
Scopis GmbH


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Neuronavigation System Market Overview
3.1 Global Neuronavigation System Market Historical Value (2016-2022)
3.2 Global Neuronavigation System Market Forecast Value (2023-2031)
4 Global Neuronavigation System Market Landscape
4.1 Global Neuronavigation System Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Neuronavigation System Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
4.2.3 Analysis by End User
5 Global Neuronavigation System Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Neuronavigation System Market Segmentation
6.1 Global Neuronavigation System Market by Product
6.1.1 Market Overview
6.1.2 Optical Systems
6.1.3 Electromagnetic Systems
6.2 Global Neuronavigation System Market by Application
6.2.1 Market Overview
6.2.2 Neurosurgery
6.2.3 ENT Surgery
6.2.4 Maxillofacial Surgery
6.2.5 Spinal Surgery
6.2.6 Others
6.3 Global Neuronavigation System Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Ambulatory Surgery Centres
6.3.4 Others
6.4 Global Neuronavigation System Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Neuronavigation System Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Neuronavigation System Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Neuronavigation System Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Neuronavigation System Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Neuronavigation System Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Stryker
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 BrainLAB AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Brainbox Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 7D Surgical System
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Siemens Healthineers
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Zimmer Biomet Holding Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Brainlab AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Scopis GmbH
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Neuronavigation System Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings